GERD (acid reflux) decisions — 2025

The Board remands the claim for a VA medical opinion to clarify whether the Veteran's gastroesophageal reflux disease was aggravated by his service-connected posttraumatic stress disorder.

The Board granted service connection for colon cancer, chronic kidney disease, and GERD but denied service connection for hypogonadism and asthma. The initial rating for diabetes mellitus type II and TDIU were also denied.

The Board granted a rating of 30 percent for gastroesophageal reflux disease, effective August 6, 2021.

The Veteran withdrew the appeal for service connection for a mental condition and an increased rating for GERD.

The Board granted service connection for gastroesophageal reflux disease (GERD) based on the evidence showing it is etiologically related to the Veteran's active duty service.

The Board granted a 30 percent disability evaluation for sinusitis but denied compensable evaluations for allergic rhinitis and coronary artery disease, and remanded the claim for service connection for gastroesophageal reflux disease.

The Board denied an initial rating in excess of 10 percent for the Veteran's service-connected GERD, as the evidence did not show symptoms that would warrant a higher evaluation.

The Board granted service connection for tubular adenoma of the colon (colon polyp) and denied service connection for frequent locking of grip in hand, left and right (tendonitis), as well as an increased rating for gastroesophageal reflux disease. The claim for headaches was remanded.

The Board remands the claims for a rating in excess of 50 percent for PTSD with polysubstance use disorder and schizoaffective disorder before January 17, 2019, a rating in excess of 70 percent thereafter, and entitlement to TDIU before January 17, 2019, for issuance of a Supplemental Statement of the Case.

The Board denied service connection for sleep apnea, memory loss, blood disorder, PTSD, lower back disorder, and gastrointestinal disorder, to include GERD, as there was no evidence of a current disability or nexus to active duty.

The Board denied service connection for GERD, gastritis, and chronic constipation as the evidence did not show that these conditions began during active service or are otherwise related to an in-service injury, event, or disease.

The Board granted service connection for GERD, secondary to the Veteran's service-connected anxiety and depression. The evidence is in approximate balance supporting a causal connection between the Veteran's GERD and his service-connected disabilities.

The Board denied a compensable rating for right knee strain with limitation of flexion and granted a separate 10 percent rating for right knee instability. The claims for increased ratings for GERD and left lower extremity radiculopathy were remanded.

The Board denied service connection for GERD, finding no evidence that the condition began during active service or was caused by a service-connected disability.

The Board denied the Veteran's appeal for an initial disability rating higher than 10 percent for gastroesophageal reflux disease (GERD) as there was no evidence of considerable or severe impairment of health during the period on appeal.

The Board remands the claim for a new examination to correct a pre-decisional duty-to-assist error, specifically addressing the impact of medications on the Veteran's symptoms.

The Board granted a disability rating of 30 percent for the Veteran's service-connected GERD, finding that the symptoms documented are productive of considerable impairment of health.

The Board granted service connection for gastroesophageal reflux disease (GERD), to include as secondary to the Veteran's service-connected conditions, resolving any reasonable doubt in favor of the Veteran.

The Board denied an initial rating in excess of 10 percent for service-connected GERD, finding that the Veteran's symptoms did not more nearly approximate considerable impairment of health.

The Board denied the Veteran's appeal for a rating higher than 20 percent for peptic ulcer disease with GERD and chronic diarrhea, as the evidence did not support a higher rating.